Analysis Titer of Epidermal Growth Factor Receptor on Nasopharyngeal Cancer Patients Based on Stadium and Histopathological Profile in Dr. Zainoel Abidin General Hospital Banda Aceh
Keywords:Nasopharyngeal carcinoma, EGFR, stage, histopathological profile
Nasopharyngeal carcinoma ranks first in incidence at the head and the neck departement. Epidermal Growth Factor Receptor (EGFR) is a transmembrane tyrosine kinase receptor from the ErbB family. Excess EGFR titer is an indication of a malignant transformation and cell differentiation that can ultimately determine the effectiveness of using anti EGFR drugs nasopharyngeal carcinoma patients.
To determine the EGFR titer of nasopharyngeal cancer tissue based on the stage and histopathological profile in Dr. Zainoel Abidin Banda Aceh.
Patients with suspected nasopharyngeal carcinoma were subjected to a nasopharyngeal biopsy examination, some samples were sent to the Anatomical Pathology Laboratory of the General Hospital Dr. Zainoel Abidin Banda Aceh for histopathological examination and some were sent to the Research Laboratory of the Faculty of Dentistry, Syiah Kuala University for examination of EGFR titers. This study was conducted from January 2020 to October 2020.
There were 17 samples of nasopharyngeal carcinoma. Based on the results of the Paired T test analysis, it can be seen that there is a difference in the quantity of EGFR titers of each study subject with the variable stage and histopathological profile. Specifically, the Paired T test analysis between EGFR titers and Stadium (P<0.05; 0.00); and analysis of EGFR titer with histopathological profile (P<0.05; 0.00). In general, the Friedmann test analysis showed that there were significant differences in the incidence of nasopharyngeal carcinoma in patients with regard to age, histopathological profile and stage (P<0.05).
EGFR titer quantity has a positive relationship with nasopharyngeal carcinoma stage and there is no relationship between EGFR titer and histopathological profile of nasopharyngeal carcinoma
Bailey BJ, Healey GB, Johnson JT, Rosen CA et al.. Head and Neck Surgery-Otolaryngology. Nasopharyngal cancer. 5th Edition. Philadelphia. Lippincott Williams & Wilkins. 2014 : 1875-97
Hsu W-L, Chen J-Y, Chien Y-C, Independent Efect of EBV and Cigarette Smoking on Nasopharyngeal Carcinoma: A 20-Year Follow-Up Study on 9,622 Males without Family History in Taiwan. Cancer Epidemiol Biomarkers Prev. 2015;18:1218-26. DOI: https://doi.org/10.1158 / 1055-9965
Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo dkk. Nasopharyngeal carcinoma in Indonesia : epidemiology, incidence, sign, and symptoms at presentation. Chin Journal of Cancer, 2012. Vol. 31(4):185-96. DOI: https://doi.org/10.5732/cjc.011.10328
Chan J.K.C, Bray F, Mc Carron P, Foo W. Nasopharyngeal carcinoma in Barnes L, Eveson JW, Reichart P, Sidrasky D editors. WHO classification of tumors: Pathology and genetics head and neck tumors Lyon 2005.85-97
Shah JP. Atlas of Clinical Oncology Cancer of the Head and Neck. Hamilton, London: BC Decker Inc; 2001
Ruan, L., Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome science, 2011. 9: p. 35-35. DOI: 10.1186/1477-5956-9-35
Ma, B.B., Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Investigational new drugs, 2010. 28(3): p. 326-333. DOI: https://doi.org/10.1007/s10637-009-9316-7
Pan, J, The clinical significance of coexpression of cyclooxygenases‐2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma. The Laryngoscope, 2008. 118(11): p. 1970-1975. DOI: https://doi.org/10.1097/MLG.0b013e3181805134
Histawara, Subroto. Ekspresi Epidermal Growth Factor Receptor Pada Karsinoma Nasofaring Subtipe Tidak Berkeratin Di Rsup Dr. M. Djamil, Padang. [Thesis]. Universitas Negeri Padang2016
Prabowo I, Juliyanto A, Setiamika A. EGFR Expression in Nasopharyngeal Carcinoma (Undifferentiated Carcinoma) type III WHO in Moewardi Hospital, Surakarta. IFHNOS 2014, New York, USA.
Rahman Sukri, Expression of epidermal growth factor receptor in advance stage nonkeratinizing nasopharyngeal carcinoma in west Sumatra, Indonesia. Archive of Oncology 2018. DOI: https://doi.org/10.2298/AOO180401005R
Prabowo I, Zuliyanto A, Setiamika M, Sudrajad H, Anggraini AH, Budiani DR, Cornain S, Nasar M, Oyong. The Relation Of Ebna-1 And Egfr Expression Screening From Advanced Stage Undifferentiated Nasopharyngeal Cancer. International Journal of Nasopharyngeal Carcinoma (IJNPC) Vol. 01, No. 02, 2019: 55-60. DOI: https://doi.org/10.32734/ijnpc.v1i2.1148
Rayego Mateos, Role of Epidermal Growth Factor Receptor (EGFR) and its ligands in kidney inflammation and damage. Mediators of inflammation, 2018. 2018.Shah JP. Atlas of Clinical Oncology Cancer of the Head and Neck. Hamilton, London: BC Decker Inc; 2001. DOI: https://doi.org/10.1155/2018/8739473
Bray F, Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiology and Prevention Biomarkers, 2008. 17(9): p. 2356-2365. DOI: https://doi.org/10.1158/1055-9965.EPI-08-0461
Xie JD, Old age at diagnosis increases risk of tumor progression in nasopharyngeal cancer. Oncotarget, 2016. 7(40): p. 66170-66181.
Botezatu A, Mechanisms of Oncogene Activation. New Aspects in Molecular and Cellular Mechanisms of Human Carcinogenesis (ed. Bulgin D), 2016: p. 1-52. DOI: https://doi.org/10.18632/oncotarget.10818
Utomo AW, IA Gustarini, The Association Between Expression Of Epidermal Growth Factor Receptor With Primary Tumor Volume Of Nasopharyngeal Carcinoma. International Journal Of Nasopharyngeal Carcinoma (IJNPC), 2019. 1(01): p. 36-40. DOI: https://doi.org/10.32734/ijnpc.v1i1.961
Tulalamba W, Janvilisri T, Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers. International journal of cell biology, 2012. 2012. DOI: https://doi.org/10.1155/2012/594681
Chua, D.T., Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. International Journal of Radiation Oncology* Biology* Physics, 2004. 59(1): p. 11-20. DOI: https://doi.org/10.1016/j.ijrobp.2003.10.038
Alni Diniati, Distribusi Keganasan Nasofaring Berdasarkan Pemeriksaan Histopatologi Pada Rumah Sakit Di Kota Pekanbaru Tahun 2009-2013. JOM FK Vol.3 No.1. 2016
Nuratna, I Nyoman Diwiya Abdi dan Wisesa, Ida Bagus Made Surya, Association of Epidermal Growth Factor Receptor (EGFR) with tumor location and clinicopathological aspect in head and neck squamous cell carcinoma. Bali Medical Journal (Bali Med J), Volume 5, 2016. 2: 283-289. DOI: https://doi.org/10.15562 / bmj.v5i2.228
Peng, H., et al., Anti-EGFR targeted therapy delivered before versus during radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a big-data, intelligence platform-based analysis. BMC cancer, 2018. 18(1): p. 323. DOI: https://doi.org/10.1186/s12885-018-4268-y
Grandis, J.R. and J.C. Sok, Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacology & therapeutics, 2004. 102(1): p. 37-46. DOI: https://doi.org/10.1016/j.pharmthera.2004.01.002
How to Cite
Copyright (c) 2021 INTERNATIONAL JOURNAL OF NASOPHARYNGEAL CARCINOMA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to The International Journal of Nasopharyngeal Carcinoma (IJNPC) as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from The International Journal of Nasopharyngeal Carcinoma (IJNPC).